Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Particles around 100 nm can penetrate and stay in hair follicles without passing through healthy skin, making them safe for use in topical products and useful for targeted drug delivery.

The yeast Pityrosporum ovale can cause skin allergies and infections, and antifungal treatments like ketoconazole are effective against it.

Hair grays due to oxidative stress and fewer functioning melanocytes.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Sunlight worsens hair loss; protect scalp.

HIV can cause unusual and severe skin problems that are hard to treat.

Not eating enough protein can cause hair roots to shrink and lose color, and hair to become thinner.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Superficial cryotherapy is effective and safe for treating alopecia areata, with better results when used early and frequently.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

This therapy effectively treats resistant alopecia areata with minimal side effects.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

The conclusion is that a combination of noninvasive treatments and lifestyle changes can improve skin health during menopause.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

An infant with scalp fungus was cured after extended treatment with antifungal medication.